FDA Finalizes Rule Requiring 12-Digit National Drug Code (NDC)

At a Glance

• Effective March 7, 2033, all FDA-assigned NDCs will follow a single 6-4-2 format — a 6-digit labeler code, 4-digit product code, and 2-digit package code — totaling 12 digits. Existing 10-digit NDCs will be converted by adding leading zeros.
• This rule will touch virtually every participant in the pharmaceutical supply chain — from manufacturers and repackagers to pharmacies, wholesalers, logistics providers, and payors.
• With seven years until the effective date, the clock is not necessarily ticking fast — but planning should start now. Companies with large product portfolios, complex supply chains, or legacy IT systems will need every bit of that runway. FDA has signaled it will not extend the deadline.

Following a proposed rule issued in July 2022, the US Food and Drug Administration (FDA) has issued a long-awaited final rule standardizing the National Drug Code (NDC) to a uniform 12-digit format. Published in the Federal Register on March 5, 2026, this rule will touch virtually every participant in the pharmaceutical supply chain — from manufacturers and repackagers to pharmacies, wholesalers, logistics providers, and payors. The effective date is March 7, 2033, with a three-year transition period following that date after which enforcement action is possible for drugs with labels that fail to reflect the new format.

What’s Changing?

Today, FDA assigns 10-digit NDCs in multiple configurations (4-4-2, 5-3-2, 5-4-1), creating persistent friction across systems that use different standardized formats. Effective March 7, 2033, all FDA-assigned NDCs will follow a single 6-4-2 format — a 6-digit labeler code, 4-digit product code, and 2-digit package code — totaling 12 digits. Existing 10-digit NDCs will be converted by adding leading zeros; FDA does not consider this a “new” NDC assignment.

FDA is also revising barcode label requirements to permit both linear and nonlinear barcodes, so long as the format meets standards from a widely recognized international standards development organization (e.g., GS1). Notably, existing UPC-A barcodes cannot accommodate a 12-digit NDC — GS1 has developed a new Application Identifier (AI 715) to enable encoding in GS1-128, GS1 DataBar, and 2D DataMatrix barcodes.

FDA clarified that certain biologics (i.e., certain specified human cells, tissues, and cellular and tissue-based products) may continue to use an alternative NDC format approved by FDA.

Why Does This Matter?

The NDC is the backbone of drug identification across the US health care system. Payors use it for claims adjudication and rebate calculations. Pharmacies rely on it for dispensing accuracy and controlled substances reporting. Wholesalers and logistics providers use it to track inventory and verify transactions under the Drug Supply Chain Security Act (DSCSA). A standardized format will reduce errors, streamline interoperability, and support patient safety — but only if all stakeholders update their systems in tandem. The stakes are high: mismatched formats can lead to claim denials, inventory mismatches, and compliance gaps.

This transition is intended to facilitate the adoption of a single NDC format across the entire health care industry. This is intended to eliminate the need to convert NDCs between different formats, reducing the potential for errors and the need for additional quality control and validation.

Key Dates

March 5, 2026: Final rule is published.

March 7, 2033: Effective date — FDA begins assigning 12-digit NDCs; existing 10-digit NDCs auto-convert.

March 2033 through March 2036: Transition period — 10-digit labeling is tolerated; systems must handle both formats.

After March 2036: Enforcement action is possible for noncompliant labeling.

Who Needs to Act?

Drug Manufacturers & Repackagers

• Update labeling, packaging, and barcode infrastructure.
• Label stock must be updated during the transition.
• Annual reports to FDA must reflect the 12-digit format for post-effective date labeling changes.

Wholesale Distributors & Logistics Providers

• Overhaul software and inventory management systems to process both 10- and 12-digit NDCs during the transition.

Pharmacies & Pharmacists

• Update dispensing systems, controlled substances reporting, and purchase order platforms.
• FDA has confirmed that NDC conversions do not trigger pricing or rebate renegotiation obligations.

Payors, PBMs & Health IT Vendors

• Systems must accommodate the 12-digit format by the effective date.
• Note that HIPAA’s existing 11-digit NDC standard will also need to be updated — that process is outside FDA’s authority but is expected to occur before 2033.

The Bottom Line

With seven years until the effective date, the clock is not necessarily ticking fast — but planning should start now. Companies with large product portfolios, complex supply chains, or legacy IT systems will need every bit of that runway. FDA has signaled it will not extend the deadline.